Maat Pharma
MaaT Pharma is a clinical-stage biotechnology company that develops microbiome-based therapies to improve survival rates in cancer patients. The company utilizes an AI-powered drug development platform and its own cGMP manufacturing facility to create treatments that restore microbiome function. Its pipeline includes candidates like Xervyteg® for treating acute Graft-versus-Host Disease and other immune-modulating therapies for oncology.
Biotechnology
Oncology
Healthcare
Microbiome Therapeutics
Funding summary
- Total raised
- €25.4M
- Funding rounds
- 2
Investors in Maat Pharma
Investors on record for Maat Pharma. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Maat Pharma?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors